Lucera Erick
Dyne Therapeutics, Inc. · Chief Financial Officer
Lucera Erick is listed in public filings as officer: Chief Financial Officer. This Lucera Erick insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Dyne Therapeutics, Inc. (DYN), SAB Biotherapeutics, Inc. (SABS), and Editas Medicine Inc (EDIT). Investors use Lucera Erick's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $2.3M123.9k shares | SellMay 13, 2026 | $26.6K1.4k shares | $18.36 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $2.3M125.4k shares | SellApr 1, 2026 | $106.8K5.7k shares | $18.64 | -- | |
| $1.7M105k shares | Grant / ExerciseFeb 12, 2026 | $1.7M105k shares | $16.00 | -- | |
| --131.1k shares | Grant / ExerciseFeb 12, 2026 | Disclosure amount unavailable65k shares | -- | -- | |
| $599k150k shares | Grant / ExerciseDec 16, 2025 | $598.5K150k shares | $3.99 | -- | |
| $2.2M214.5k shares | Grant / ExerciseMar 31, 2025 | $2.2M214.5k shares | $10.46 | -- | |
| --66.1k shares | Grant / ExerciseMar 31, 2025 | Disclosure amount unavailable66.1k shares | -- | -- | |
| $473k275.1k shares | Grant / ExerciseMar 8, 2025 | $473.2K275.1k shares | $1.72 | -- | |
| $120k70k shares | Grant / ExerciseMar 8, 2025 | $120.4K70k shares | $1.72 | -- | |
| $193k112.7k shares | SellMar 4, 2025 | $7.0K4.1k shares | $1.71 | -- | |
| $58k20k shares | Grant / ExerciseJul 15, 2024 | $58.0K20k shares | $2.90 | -- |